Transgenic short-QT syndrome 1 rabbits mimic the human disease phenotype with QT/action potential duration shortening in the atria and ventricles and increased ventricular tachycardia/ventricular fibrillation inducibility

Autor: David Ziupa, Heiko Bugger, Anna Ryan de Medeiros, Marius Menza, Corinna N. Lang, Stefanie Perez-Feliz, Jan C. Behrends, Michael Brunner, Naga Deepa Pantulu, Lea Mettke, Konstantin Michaelides, Zoltán Doleschall, Raphaela Rieke, Rémi Peyronnet, Geneviève Jolivet, Christoph Bode, Axel zur Hausen, Hannah E Fürniss, Ilona Bodi, Manfred Zehender, Katja E. Odening, Johannes Steinfurt, Gerlind Franke
Přispěvatelé: Department of Cardiology and Angiology I, University Heart Centre Freiburg - Bad Krozingen, University of Freiburg [Freiburg], Department of Pathology, University of Alabama at Birmingham [ Birmingham] (UAB), Department of Pathogenetics, National Institute of Oncology, Biologie du Développement et Reproduction (BDR), École nationale vétérinaire d'Alfort (ENVA)-Institut National de la Recherche Agronomique (INRA), Université Paris Saclay (COmUE), St. Josefskrankenhaus, German Research Foundation DFG-BR2107/4-1, MUMC+: DA Klinische Pathologie (5), Pathologie, RS: GROW - R2 - Basic and Translational Cancer Biology
Jazyk: angličtina
Rok vydání: 2019
Předmět:
Male
Action Potentials
030204 cardiovascular system & hematology
Ventricular tachycardia
Animals
Genetically Modified

Electrocardiography
0302 clinical medicine
MUTATION
[SDV.BDD]Life Sciences [q-bio]/Development Biology
biology
Quinidine
animal models
Phenotype
Ion channels
Cardiology
Female
Rabbits
medicine.symptom
Cardiology and Cardiovascular Medicine
Anti-Arrhythmia Agents
medicine.drug
Heart Defects
Congenital

medicine.medical_specialty
Heart Ventricles
hERG
arrhythmia
QT interval
Sudden death
03 medical and health sciences
SUDDEN-DEATH
Heart Conduction System
Internal medicine
medicine
Animals
Humans
Heart Atria
Fibrillation
business.industry
Arrhythmias
Cardiac

Short QT syndrome
030229 sport sciences
medicine.disease
electrical remodelling
Disease Models
Animal

Ventricular fibrillation
biology.protein
cardiac repolarization
business
short-QT syndrome
Zdroj: European Heart Journal
European Heart Journal, Oxford University Press (OUP): Policy B, 2019, 40 (10), pp.842-853. ⟨10.1093/eurheartj/ehy761⟩
European Heart Journal, 40(10), 842-853. Oxford University Press
ISSN: 0195-668X
1522-9645
DOI: 10.1093/eurheartj/ehy761⟩
Popis: AIMS Short-QT syndrome 1 (SQT1) is an inherited channelopathy with accelerated repolarization due to gain-of-function in HERG/IKr. Patients develop atrial fibrillation, ventricular tachycardia (VT), and sudden cardiac death with pronounced inter-individual variability in phenotype. We generated and characterized transgenic SQT1 rabbits and investigated electrical remodelling. METHODS AND RESULTS Transgenic rabbits were generated by oocyte-microinjection of β-myosin-heavy-chain-promoter-KCNH2/HERG-N588K constructs. Short-QT syndrome 1 and wild type (WT) littermates were subjected to in vivo ECG, electrophysiological studies, magnetic resonance imaging, and ex vivo action potential (AP) measurements. Electrical remodelling was assessed using patch clamp, real-time PCR, and western blot. We generated three SQT1 founders. QT interval was shorter and QT/RR slope was shallower in SQT1 than in WT (QT, 147.8 ± 2 ms vs. 166.4 ± 3, P
Databáze: OpenAIRE